Oncimmune Holdings, Nottingham
Oncimmune uses technology to improve the screening, detection and care of cancer.
Established in 2005 as a spin-out of Nottingham University, it transitioned to a commercial company with the launch in the US of two early detection blood-based tests in lung and liver cancer.
It recently appointed Dr Adam Hill, a former chief strategy officer at McLaren Applied Technologies, as CEO after founder Geoffrey Hamilton-Fairley’s decision to step down and take up a new position as vice chairman of the company's board of directors.
Check out our '101 Birmingham and Midlands’ list for more tech stars from the region.